Brief screening tools for early dementia risk are essential in primary care. A 2026 study by You et al. evaluated the AD8 informant questionnaire in older Chinese-speaking adults in Australia, mapping how cognitive, functional, social, and language-barrier risks stack before dementia is formally diagnosed.1 Research Highlights The AD8 dementia screening interview is an 8-item informant-based …
Patients with schizophrenia have substantially elevated dementia risk compared to the general population — roughly 2-3 times the age-adjusted rate — but the specific drivers within the schizophrenia population have been less well characterized. A 2026 case-control study by Ho et al. used population-based data to identify which factors specifically elevate dementia risk among schizophrenia …
The risperidone-stroke link in dementia is one of the longest-running safety signals in geriatric psychiatry, anchoring the FDA’s 2005 black-box warning on atypical antipsychotic mortality. Popular framing reduces it to “antipsychotics cause stroke in dementia” — a true sentence that flattens a multi-axis decision. Choma’s 2025 analysis of UK primary care records is the largest …
“Schizophrenia ages you faster” is the headline that gets repeated whenever a new biomarker study lands. The 2026 Fernandez-Egea, Garcia-Rizo and Kirkpatrick review — covering 170 studies across mortality, brain imaging, telomeres, epigenetic clocks, and metabolic markers — pushes back on that framing.2 The aging signal is genuine. “Accelerated” is the part that overshoots for …
Loneliness raises measured risk of Alzheimer’s, suicidal ideation, and completed suicide. The associations are documented; the precise magnitudes are not.
Modern administrative cohorts find no dementia signal for ECT and link it to lower suicide and mortality. The supportive literature carries known biases worth flagging.
Frontotemporal dementia (FTD) is a challenging and impactful neurodegenerative disease. Recent research offers new insights into its management, particularly regarding the effectiveness of pharmacological treatments. Highlights: High-Dose Oxytocin Shows Promise: High-dose oxytocin (72 international units) has been linked to significant improvements in neuropsychiatric symptoms and daily interactive activities in FTD patients. Piracetam Poses Risks: Contrarily, …